Some beaten up biotech names are finally coming back to life. Here's a look at the technical analysis.
Goldman Sachs will soon welcome a new CEO: David Solomon.
One lawyer likens the case to Big Tobacco's fight for decades against lung cancer sufferers who smoked.
Netflix earnings seriously letdown investors. Here's what investors need to be thinking about the results.